Trials / Completed
CompletedNCT06393153
Model for Prognosis of Elderly Gastric Cancer Patients
Development and Validation of a Machine Learning Model for Predicting the Prognosis of Elderly Gastric Cancer Patients: A Multi-Center Study in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,202 (actual)
- Sponsor
- Chang-Ming Huang, Prof. · Academic / Other
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to develop and validate a Random Survival Forest (RSF) model for predicting long-term survival in elderly patients following curative resection for gastric cancer. The study is a retrospective multi-center analysis involving patients aged 75 and above who underwent gastric resection from January 2009 to December 2018 at nine top-tier hospitals in China. An online prognostic tool is introduced to assist clinicians in predicting patient prognosis and customizing treatment and follow-up strategies.
Detailed description
This retrospective multi-center study focuses on the development and validation of a predictive model for elderly gastric cancer patients. Data were collected from 16,344 gastric cancer patients, with 1,202 elderly patients ultimately included after applying exclusion criteria. Patients were randomly divided into training and testing cohorts in a 7:3 ratio. The study was approved by the institutional review boards with a waiver of informed consent due to the use of anonymized secondary data. The analysis employs the Random Survival Forest (RSF) method, incorporating variable importance and minimal depth techniques to select key variables for predicting overall survival (OS) and disease-free survival (DFS). The study also implements rigorous data handling procedures, including multiple imputations for missing data. The development of an online prognostic tool based on the RSF model is part of the project, designed to provide real-time survival predictions through a user-friendly interface for clinical application.
Conditions
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-04-01
- Completion
- 2024-04-20
- First posted
- 2024-05-01
- Last updated
- 2024-05-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06393153. Inclusion in this directory is not an endorsement.